ILSbio Selected to Participate:
ILSbio, LLC is proud to announce their selection as a tissue supplier for "The Cancer Genome Atlas".  The Cancer Genome Atlas (TCGA) is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing. TCGA is a joint effort of the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), which are both part of the National Institutes of Health, U.S. Department of Health and Human Services.

Giving Back to Our Sources:
Over the years, ILSBio has worked with health officials in our host countries to implement screening programs – most notably country-wide clinical breast exams, Pap screening, Hepatitis B vaccination and treatment, and HIV screening of pregnant women, as well as, patient education and outreach prevention programs.

ILSBio has also conducted major cancer conferences, and various surgical and radiology short courses and seminars in our partner countries.  To date, ILSBio has sponsored fellowships and observerships for over 30 visiting physicians at major U.S. institutions including Stanford, M.D. Anderson, Dana Farber, Johns Hopkins, Columbia, University of Pennsylvania, New York University and University of Iowa.  ILSBio has brought our collaborators to the U.S. for them to present the results of our joint collaborations at major conferences (i.e. Pap Screening Implementation at the U.S./Canadian Academy of Pathology Annual Meeting and at the International Cervical Cancer Conference held at M.D. Anderson Cancer Center).

 This summer, ILSBio is sponsoring the visits of 6 physicians and one hospital director for training and collaboration introductions.  Topics include: FISH Her2neu analysis, a surgical pathology observership and obtaining partners for the implementation of a heart transplantation surgery program. In August, an additional young pathologist will commence his 1-year fellowship in molecular level diagnostics at Stanford.

ILSBio has received many awards and honors from health officials in our host countries (i.e. ILSBio was recently cited for an award by the Minister of Health of one of our host countries for arranging no cost PCR screening of patient blood samples during a recent Dengue Fever epidemic. We are currently jointly conducting a no cost BRACA1 & 2 incidence study in another host country.  

Our personnel are very proud of these accomplishments and hope that some day our source of cancer research tissues in these countries will begin to diminish. 

Epigenetics change neuroblastoma phenotype

VEGF for monitoring response to chemotherapy

CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion

Risk of breast cancer among daughters of mothers with diabetes: a population-based cohort study

Industry Awards

2010 Biotechnology Heritage Award
Arthur D. Levinson (CHF News Release)

Cancer Genetics Pioneer Wins Margaret Kripke Legend Award  (MD Anderson News Release)

AACR Applauds Presidential Nomination of Harold E. Varmus, M.D., as Director of the National Cancer Institute (AACR News Release)

Industry Events

Current AACR Calendar of Events

TechCouncil of MD Calendar of Events

Medical and Pharmaceutical Industry Events

Quote of the Month

"If we knew what we were doing, it would not be called research, would it"

Albert Einstein

Send your companies news and important industry events to:
info@ilsbio.com